NCT05639010View on ClinicalTrials.gov

Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study

NARecruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
End Stage Renal Disease
Interventions
DEVICE

regular hemodialysis

Routine blood purification therapy (including hemodialysis, hemofiltration) 3 times a week

DEVICE

hemoperfusion combined with hemodialysis

Hemoperfusion combined with hemodialysis treatment will perform once a week. The hemoperfusion apparatus will use type KHA80 hemoperfusion apparatus (Zhuhai Jafron Biomedical Co., Ltd, China)

Trial Locations (1)

200433

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER